Article(id=1322627326051992089, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322627316266680781, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1591372800000, acceptedDateStr=2020-06-06, onlineDate=1793268527758, onlineDateStr=2026-10-29, pubDate=1611936000000, pubDateStr=2021-01-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793268527758, onlineIssueDateStr=2026-10-29, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793268527758, creator=13701087609, updateTime=1793268527758, updator=13701087609, issue=Issue{id=1322627316266680781, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='2', pageStart='97', pageEnd='192', issueExtLink='null', onlineDate='null', pubDate='1611936000000', pubDateStr='2021-01-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793268525425, creator='13701087609', updateTime=1793269089393, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322629681875108722, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322627316266680781, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322629681879303027, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322627316266680781, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=97, endPage=104, ext={EN=ArticleExt(id=1322627326244930074, articleId=1322627326051992089, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=The new development of the Right to Try Act on the expanded access of investigational new drugs in the USA, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

By referring to the laws and regulations of the United States, FDA guidance documents and implementation guidelines, related news, domestic and foreign literature, we analyzed more deeply the background, content system, social disputes caused by the Right to Try Act and its important breakthroughs of the existing expanded access in this paper, so as to provide reference for the system innovation in China. Although the Right to Try Act emphasizes deregulation, simplification of procedures and relative risk control, it also emphasizes the widening of critically ill patients' right of free choice. Therefore, it is required that the introduction and construction of relevant system norms be comprehensively measured and prudently promoted in Chinese context.

, authors=Zhang-zhi GE, authorsList=Zhang-zhi GE, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322627326458839579, articleId=1322627326051992089, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=美国尝试权法案对临床试验用药物扩大使用制度的新发展, columnId=1236331162679955859, journalTitle=中国新药杂志, columnName=新药述评与论坛, runingTitle=null, highlight=null, articleAbstract=

通过查阅美国的法律法规、FDA指南文件和实施准则、新闻报道和国内外文献,本文深入分析尝试权法案的产生背景、内容体系、引发的社会争议及其对已有扩大使用制度的重要突破,为我国相关制度规范的设计和创新提供借鉴。尝试权法案虽然强调放松监管、简化程序和相对风险控制,但更为重要的是拓宽了危重患者的选择权。立足中国国情,我们需全面衡量并审慎推进相关制度规范的引入和建设。

, authors=葛章志, authorsList=葛章志, authorCompany=null, correspAuthors=null, authorNote=

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=xEfQ5UXYB9O7GYPx/Jzexg==, magXml=hFbMpfQ7gcc/N2V8yg+cCQ==, pdfUrl=null, pdf=P65VvJD/jkC/uf4hXvx4pQ==, pdfFileSize=1556351, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=694FoYYNthjPXSu2/KhA5w==, mapNumber=null, fund=null)}, authors=[Author(id=1322627326777606688, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=gezhangzhi2008@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322627326836326946, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, authorId=1322627326777606688, language=EN, stringName=Zhang-zhi GE, firstName=Zhang-zhi, middleName=null, lastName=GE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=University of Science and Technology of China, Hefei 230026, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322627326911824419, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, authorId=1322627326777606688, language=CN, stringName=葛章志, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国科学技术大学,合肥 230026, bio={"content":"

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

"}, bioImg=null, bioContent=

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322627326685331996, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, xref=null, ext=[AuthorCompanyExt(id=1322627326693720605, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=University of Science and Technology of China, Hefei 230026, China), AuthorCompanyExt(id=1322627326702109214, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国科学技术大学,合肥 230026)])])], keywords=[Keyword(id=1322627327004099108, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=EN, orderNo=1, keyword=Right to Try Act), Keyword(id=1322627327075402277, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=EN, orderNo=2, keyword=clinical trial), Keyword(id=1322627327167676966, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=EN, orderNo=3, keyword=expanded access), Keyword(id=1322627327230591527, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=EN, orderNo=4, keyword=option), Keyword(id=1322627327289311784, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=CN, orderNo=1, keyword=尝试权法案), Keyword(id=1322627327352226345, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=CN, orderNo=2, keyword=临床试验), Keyword(id=1322627327436112426, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=CN, orderNo=3, keyword=扩大使用), Keyword(id=1322627327511609899, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, language=CN, orderNo=4, keyword=选择权)], refs=[Reference(id=1322627327683576365, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Expanded Access | Information for Patients[EB/OL]. (2019-05-20) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-information-patients., articleTitle=null, refAbstract=null), Reference(id=1322627327767462446, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Expanded Access[EB/OL]. (2019-05-06) [2020-02-05]. https://www.fda.gov/news-events/public-health-focus/expanded-access., articleTitle=null, refAbstract=null), Reference(id=1322627327834571311, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Right to try. Nebraska Becomes 40th State to Adopt Right to Try Law[EB/OL]. (2018-04-24) [2020-02-11]. http://righttotry.org/nebraska-becomes-40th-state-to-adopt-right-to-try-law/., articleTitle=null, refAbstract=null), Reference(id=1322627327901680176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Right to try. Dead on Arrival: Federal “Compassionate Use” Leaves Little Hope for Dying Patients[EB/OL]. (2016-02-24) [2020-02-11]. http://righttotry.org/dead-on-arrival/., articleTitle=null, refAbstract=null), Reference(id=1322627327981371953, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=THE HILL. “Right to try” is a win for patient rights and President Trump[EB/OL]. (2018-05-26) [2020-01-19]. https://thehill.com/opinion/healthcare/389514-right-to-try-is-a-win-for-patient-rights-and-president-trump., articleTitle=null, refAbstract=null), Reference(id=1322627328052675122, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Fox News. Trump signs “Right to Try”, says it will save “tremendous number of lives”[EB/OL]. (2018-05-30) [2020-01-07]. https://www.foxnews.com/politics/trump-signs-right-to-try-says-it-will-save-tremendous-number-of-lives., articleTitle=null, refAbstract=null), Reference(id=1322627328128172595, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=孙宇昕, 魏芬芳, 冯霄婵, 等. 美国临床试验用药物扩大使用制度沿革与发展[J]. 中国新药杂志, 2017, 26(16): 1880-1886., articleTitle=null, refAbstract=null), Reference(id=1322627329772339764, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=115s204enr[EB/OL]. [2020-02-15]. https://www.congress.gov/115/bills/s204/BILLS-115s204enr.pdf., articleTitle=null, refAbstract=null), Reference(id=1322627329839448629, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ROTHCLINE M, NELSON R. FDA implementation of the expanded access program in the United States[J]. Am J Bioeth, 2014, 14(11): 17-19., articleTitle=null, refAbstract=null), Reference(id=1322627329914946102, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Expanded Access | How to Submit a Request (Forms)[EB/OL]. (2019-09-17) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-how-submit-request-forms., articleTitle=null, refAbstract=null), Reference(id=1322627329977860663, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Right to Try[EB/OL]. (2020-01-04) [2020-02-05]. https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try., articleTitle=null, refAbstract=null), Reference(id=1322627330036580920, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=WONG CH, SIAH KW, LO AW. Estimation of clinical trial success rates and related parameters[J]. Biostatistics, 2019, 20(2): 273-286., articleTitle=null, refAbstract=null), Reference(id=1322627330195964473, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CBSNEWS. What is “right to try” and will it help terminally ill patients?[EB/OL]. (2018-05-30) [2020-02-15]. https://www.cbsnews.com/news/right-to-try-bill-trump-signing-will-it-help-terminally-ill-patients-today-2018-05-30/., articleTitle=null, refAbstract=null), Reference(id=1322627330258879034, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Expanded Access (compassionateuse) submission data[EB/OL]. (2019-05-20) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-compassionate-use-submission-data., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322627327599690284, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, awardId=WK2160000008, language=CN, fundingSource=中央高校基本科研业务费创新团队培育基金项目“大健康环境下‘医养科教’结合模式与实施路径(WK2160000008), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322627326685331996, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, xref=null, ext=[AuthorCompanyExt(id=1322627326693720605, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=University of Science and Technology of China, Hefei 230026, China), AuthorCompanyExt(id=1322627326702109214, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国科学技术大学,合肥 230026)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I2/97, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I2/97, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I2/97, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I2/97, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1611936000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
美国尝试权法案对临床试验用药物扩大使用制度的新发展
收藏切换
PDF下载
葛章志
中国新药杂志 | 新药述评与论坛 2021,30(2): 97-104
收起
收藏切换
中国新药杂志 |新药述评与论坛 2021 , 30 (2) : 97 -104
美国尝试权法案对临床试验用药物扩大使用制度的新发展
全屏
[Author(id=1322627326777606688, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=gezhangzhi2008@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322627326836326946, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, authorId=1322627326777606688, language=EN, stringName=Zhang-zhi GE, firstName=Zhang-zhi, middleName=null, lastName=GE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=University of Science and Technology of China, Hefei 230026, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322627326911824419, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, authorId=1322627326777606688, language=CN, stringName=葛章志, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国科学技术大学,合肥 230026, bio={"content":"

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

"}, bioImg=null, bioContent=

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322627326685331996, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, xref=null, ext=[AuthorCompanyExt(id=1322627326693720605, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=University of Science and Technology of China, Hefei 230026, China), AuthorCompanyExt(id=1322627326702109214, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322627326051992089, companyId=1322627326685331996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国科学技术大学,合肥 230026)])])]
葛章志
作者信息
  • 中国科学技术大学,合肥 230026
作者简介:

葛章志,男,副研究员,主要从事公共健康政策研究。联系电话:(0551)63607551,E-mail:。

The new development of the Right to Try Act on the expanded access of investigational new drugs in the USA
Zhang-zhi GE
Affiliations
  • University of Science and Technology of China, Hefei 230026, China
出版时间: 2021-01-30
文章导航
收藏切换

通过查阅美国的法律法规、FDA指南文件和实施准则、新闻报道和国内外文献,本文深入分析尝试权法案的产生背景、内容体系、引发的社会争议及其对已有扩大使用制度的重要突破,为我国相关制度规范的设计和创新提供借鉴。尝试权法案虽然强调放松监管、简化程序和相对风险控制,但更为重要的是拓宽了危重患者的选择权。立足中国国情,我们需全面衡量并审慎推进相关制度规范的引入和建设。

尝试权法案  /  临床试验  /  扩大使用  /  选择权

By referring to the laws and regulations of the United States, FDA guidance documents and implementation guidelines, related news, domestic and foreign literature, we analyzed more deeply the background, content system, social disputes caused by the Right to Try Act and its important breakthroughs of the existing expanded access in this paper, so as to provide reference for the system innovation in China. Although the Right to Try Act emphasizes deregulation, simplification of procedures and relative risk control, it also emphasizes the widening of critically ill patients' right of free choice. Therefore, it is required that the introduction and construction of relevant system norms be comprehensively measured and prudently promoted in Chinese context.

Right to Try Act  /  clinical trial  /  expanded access  /  option
葛章志. 美国尝试权法案对临床试验用药物扩大使用制度的新发展. 中国新药杂志, 2021 , 30 (2) : 97 -104 .
Zhang-zhi GE. The new development of the Right to Try Act on the expanded access of investigational new drugs in the USA[J]. Chinese Journal of New Drugs, 2021 , 30 (2) : 97 -104 .
  • 中央高校基本科研业务费创新团队培育基金项目“大健康环境下‘医养科教’结合模式与实施路径(WK2160000008)
参考文献 引证文献
排序方式:
[1]
FDA. Expanded Access | Information for Patients[EB/OL]. (2019-05-20) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-information-patients.
[2]
FDA. Expanded Access[EB/OL]. (2019-05-06) [2020-02-05]. https://www.fda.gov/news-events/public-health-focus/expanded-access.
[3]
Right to try. Nebraska Becomes 40th State to Adopt Right to Try Law[EB/OL]. (2018-04-24) [2020-02-11]. http://righttotry.org/nebraska-becomes-40th-state-to-adopt-right-to-try-law/.
[4]
Right to try. Dead on Arrival: Federal “Compassionate Use” Leaves Little Hope for Dying Patients[EB/OL]. (2016-02-24) [2020-02-11]. http://righttotry.org/dead-on-arrival/.
[5]
THE HILL. “Right to try” is a win for patient rights and President Trump[EB/OL]. (2018-05-26) [2020-01-19]. https://thehill.com/opinion/healthcare/389514-right-to-try-is-a-win-for-patient-rights-and-president-trump.
[6]
Fox News. Trump signs “Right to Try”, says it will save “tremendous number of lives”[EB/OL]. (2018-05-30) [2020-01-07]. https://www.foxnews.com/politics/trump-signs-right-to-try-says-it-will-save-tremendous-number-of-lives.
[7]
孙宇昕, 魏芬芳, 冯霄婵, 等. 美国临床试验用药物扩大使用制度沿革与发展[J]. 中国新药杂志, 2017, 26(16): 1880-1886.
[8]
115s204enr[EB/OL]. [2020-02-15]. https://www.congress.gov/115/bills/s204/BILLS-115s204enr.pdf.
[9]
ROTHCLINE M, NELSON R. FDA implementation of the expanded access program in the United States[J]. Am J Bioeth, 2014, 14(11): 17-19.
[10]
FDA. Expanded Access | How to Submit a Request (Forms)[EB/OL]. (2019-09-17) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-how-submit-request-forms.
[11]
FDA. Right to Try[EB/OL]. (2020-01-04) [2020-02-05]. https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/right-try.
[12]
WONG CH, SIAH KW, LO AW. Estimation of clinical trial success rates and related parameters[J]. Biostatistics, 2019, 20(2): 273-286.
[13]
CBSNEWS. What is “right to try” and will it help terminally ill patients?[EB/OL]. (2018-05-30) [2020-02-15]. https://www.cbsnews.com/news/right-to-try-bill-trump-signing-will-it-help-terminally-ill-patients-today-2018-05-30/.
[14]
FDA. Expanded Access (compassionateuse) submission data[EB/OL]. (2019-05-20) [2020-02-05]. https://www.fda.gov/news-events/expanded-access/expanded-access-compassionate-use-submission-data.
2021年第30卷第2期
PDF下载
14
5
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-29
  • 出版时间:2021-01-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2020-06-06
基金
中央高校基本科研业务费创新团队培育基金项目“大健康环境下‘医养科教’结合模式与实施路径(WK2160000008)
作者信息
    中国科学技术大学,合肥 230026
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322627326051992089
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏